Sustainability Report

Overview

The report presents Blau Farmacêutica's consolidated operations in Brazil, its subsidiaries and the United States for 2022. It highlights record net revenue of BRL 1.407 billion, 19 new medicines for Brazil and 25 new registrations in Latin America. The company established an ESG Committee with Board representation and reports material topics spanning social, human-capital and environmental issues. Environmental disclosures include 94.74 m3 of water consumed.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services